Correlation Between Mega Lifesciences and Carabao Group

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mega Lifesciences and Carabao Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mega Lifesciences and Carabao Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mega Lifesciences Public and Carabao Group Public, you can compare the effects of market volatilities on Mega Lifesciences and Carabao Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mega Lifesciences with a short position of Carabao Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mega Lifesciences and Carabao Group.

Diversification Opportunities for Mega Lifesciences and Carabao Group

0.19
  Correlation Coefficient

Average diversification

The 3 months correlation between Mega and Carabao is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Mega Lifesciences Public and Carabao Group Public in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Carabao Group Public and Mega Lifesciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mega Lifesciences Public are associated (or correlated) with Carabao Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Carabao Group Public has no effect on the direction of Mega Lifesciences i.e., Mega Lifesciences and Carabao Group go up and down completely randomly.

Pair Corralation between Mega Lifesciences and Carabao Group

Assuming the 90 days trading horizon Mega Lifesciences Public is expected to generate 0.9 times more return on investment than Carabao Group. However, Mega Lifesciences Public is 1.11 times less risky than Carabao Group. It trades about -0.04 of its potential returns per unit of risk. Carabao Group Public is currently generating about -0.17 per unit of risk. If you would invest  3,275  in Mega Lifesciences Public on December 30, 2024 and sell it today you would lose (225.00) from holding Mega Lifesciences Public or give up 6.87% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Mega Lifesciences Public  vs.  Carabao Group Public

 Performance 
       Timeline  
Mega Lifesciences Public 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Mega Lifesciences Public has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent forward-looking signals, Mega Lifesciences is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.
Carabao Group Public 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Carabao Group Public has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's technical and fundamental indicators remain quite persistent which may send shares a bit higher in April 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Mega Lifesciences and Carabao Group Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mega Lifesciences and Carabao Group

The main advantage of trading using opposite Mega Lifesciences and Carabao Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mega Lifesciences position performs unexpectedly, Carabao Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Carabao Group will offset losses from the drop in Carabao Group's long position.
The idea behind Mega Lifesciences Public and Carabao Group Public pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum